SUBSCRIBE
SUBSCRIBE
News   Drug Development

Study Backs Roche Holding AG’s (JOBS) New Use of Avastin Cancer Drug

August 18, 2009 | 
1 min read
Bookmark and Share

Reuters -- Swiss-based Roche Holding AG said on Tuesday a study had showed its drug Avastin increased life expectancy for women with breast cancer without the disease getting worse, when used alongside common chemotherapies.
Clinical research Phase 3 Europe
MORE ON THIS TOPIC
Podcast
Biogen validates anti-tau approach at AAIC, psychedelics full speed ahead, ATTR-CM shakeup
July 15, 2026
 · 
1 min read
 · 
Jef Akst
Brain neuro cell growth or damaging drawing with texture shading illustration isolated on dark background
Alzheimer’s disease
AAIC 2026: Lilly keeps door open for maintenance Kisunla after amyloid clearance
July 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Baseball background design. Vector illustration of sports concept
Manufacturing
Manufacturing issues prompt FDA to reject Hengrui-Elevar filings for third time
July 15, 2026
 · 
1 min read
 · 
Nick Paul Taylor
FDA headquarters with a purple psychedelic background.
Psychedelics
Final psychedelics guidance suggests FDA is ‘receptive’ to helping companies succeed
July 14, 2026
 · 
3 min read
 · 
Michael Gibney